Jan 4, 2026 · Xgeva prevents bone fractures and other skeletal conditions in people with multiple myeloma, and is also used to treat giant cell tumor of bone and lower blood calcium levels in patients …

XGEVA ® is a prescription medicine used to prevent fracture, spinal cord compression, or the need for radiation or surgery to bone in patients with multiple myeloma and in patients with bone metastases …

Review how to administer the 120mg subcutaneous (SC) dose and the dosing schedule of XGEVA® (denosumab). See full Prescribing & Safety Info.

Jul 30, 2025 · Xgeva (denosumab) Injection is a human IgG2 monoclonal antibody used to treat bone problems that may occur with cancer that has spread (metastasized) to the bones.

The safety and efficacy of Xgeva for the prevention of skeletal-related events in patients with bone metastases from solid tumors was demonstrated in three international, randomized (1:1),...

Sep 16, 2025 · 2.1 Important Administration Instructions - Xgeva should be administered by a healthcare provider. Xgeva is intended for subcutaneous route only and should not be administered ...

XGEVA ®, also called denosumab, is prescribed for people with bone metastases from breast, prostate, and other solid tumors (cancer) and for people with multiple myeloma.

Apr 20, 2025 · Denosumab (Xgeva®) is a monoclonal antibody medication used for the prevention of bone metastasis in patients with multiple myeloma, breast, prostate, lung and other solid tumor cancers.

6 days ago · Easy-to-read patient tips for Xgeva covering how it works, benefits, risks, and best practices.

May 22, 2024 · Xgeva (denosumab) is a prescription drug that’s given as an injection. It treats bone cancers and hypercalcemia and helps prevent broken bones. Learn about side effects and more.